Traws Pharma (TRAW) Tops Q1 EPS by 209c
Tweet
Share
E-mailGet Alerts TRAW Hot Sheet
Join SI Premium – FREE
Traws Pharma (NASDAQ: TRAW) reported Q1 EPS of $2.09. Revenue for the quarter came in at $60 thousand.
For earnings history and earnings-related data on Traws Pharma (TRAW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kalshi in early talks for IPO - The Information
- Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
- JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
